129 related articles for article (PubMed ID: 18050970)
1. Computer-assisted quantitative analysis of Ki-67 antigen in dysplasia--associated lesions or masses in ulcerative colitis.
Zivković V; Petrović A; Dordević B; Katić V; Gligorijević J; Pavlović V; Krstić M
Vojnosanit Pregl; 2007 Nov; 64(11):753-8. PubMed ID: 18050970
[TBL] [Abstract][Full Text] [Related]
2. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.
Noffsinger AE; Miller MA; Cusi MV; Fenoglio-Preiser CM
Cancer; 1996 Dec; 78(11):2307-12. PubMed ID: 8940999
[TBL] [Abstract][Full Text] [Related]
3. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.
Andersen SN; Rognum TO; Bakka A; Clausen OP
Mol Pathol; 1998 Dec; 51(6):327-32. PubMed ID: 10193513
[TBL] [Abstract][Full Text] [Related]
4. High proliferative activity is associated with dysplasia in ulcerative colitis.
Shinozaki M; Watanabe T; Kubota Y; Sawada T; Nagawa H; Muto T
Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S34-9. PubMed ID: 11052476
[TBL] [Abstract][Full Text] [Related]
5. Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones.
Tokuyama W; Mikami T; Fujiwara M; Matsui T; Okayasu I
Pathol Int; 2007 May; 57(5):260-7. PubMed ID: 17493173
[TBL] [Abstract][Full Text] [Related]
6. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
AbdElazeem MA; El-Sayed M
Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
[TBL] [Abstract][Full Text] [Related]
7. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease.
Kullmann F; Fadaie M; Gross V; Knüchel R; Bocker T; Steinbach P; Schölmerich J; Rüschoff J
Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):371-9. PubMed ID: 8781908
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
Maruyama K; Saigusa N; Baba S; Kino I
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778
[TBL] [Abstract][Full Text] [Related]
9. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
Gui X; Liu S; Yan Y; Gao Z
World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
[TBL] [Abstract][Full Text] [Related]
12. Severe dysplasia can be distinguished from moderate and mild dysplasia of bronchial mucosa by changes in Ki-67 index.
Mijović Ž; Mihailović D
Pol J Pathol; 2015 Mar; 66(1):38-43. PubMed ID: 26017878
[TBL] [Abstract][Full Text] [Related]
13. COX-2 and Ki-67 immunohistochemical markers in the assessment of long-standing ulcerative colitis associated dysplasia.
Frăţilă OC; Iliaş TI
Rom J Morphol Embryol; 2013; 54(1):143-9. PubMed ID: 23529322
[TBL] [Abstract][Full Text] [Related]
14. Evidence for immunosurveillance in intestinal premalignant lesions.
Karlsson M; Lindberg K; Karlén P; Ost A; Thörn M; Winqvist O; Eberhardson M
Scand J Immunol; 2010 May; 71(5):362-8. PubMed ID: 20500687
[TBL] [Abstract][Full Text] [Related]
15. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
Stenling R; Lindberg J; Rutegård J; Palmqvist R
APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment of a unique basal pattern of p53 expression in ulcerative-colitis-associated neoplasia using computer-assisted cytometry.
Kobayashi S; Fujimori T; Mitomi H; Tomita S; Ichikawa K; Imura J; Fujii S; Itabashi M; Kameoka S; Igarashi Y
Diagn Pathol; 2014 May; 9():99. PubMed ID: 24886509
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia.
Wong NA; Mayer NJ; MacKell S; Gilmour HM; Harrison DJ
Histopathology; 2000 Aug; 37(2):108-14. PubMed ID: 10931232
[TBL] [Abstract][Full Text] [Related]
19. [Morphological and immunohistochemical quantitative analysis of dysplasia in ulcerative colitis. 1. Histological mapping specimen and morphological quantitative analysis].
Oikawa T
Nihon Shokakibyo Gakkai Zasshi; 1992 Feb; 89(2):477-85. PubMed ID: 1569702
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal carcinoma-associated antigen detected by a monoclonal antibody in dysplasia and adenocarcinoma associated with chronic ulcerative colitis.
Olding LB; Ahren C; Thurin J; Karlsson KA; Svalander C; Koprowski H
Int J Cancer; 1985 Aug; 36(2):131-6. PubMed ID: 4018908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]